These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36523928)

  • 21. Staged hepatectomy after emergency transcatheter arterial embolization for ruptured hepatocellular carcinoma.
    Shimada R; Imamura H; Makuuchi M; Soeda J; Kobayashi A; Noike T; Miyagawa S; Kawasaki S
    Surgery; 1998 Sep; 124(3):526-35. PubMed ID: 9736905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy.
    Wu JJ; Zhu P; Zhang ZG; Zhang BX; Shu C; Mba'nbo-Koumpa AA; Zhang ZW; Huang ZY; Zhang WG; Lau WY; Chen XP
    Eur J Surg Oncol; 2019 Oct; 45(10):1887-1894. PubMed ID: 31405632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
    Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study.
    Yang H; Chen K; Wei Y; Liu F; Li H; Zhou Z; Li B
    Pak J Med Sci; 2014 May; 30(3):472-6. PubMed ID: 24948961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intended preoperative trans-arterial embolization for large hepatocellular carcinoma: a retrospective cohort study.
    Saito R; Amemiya H; Hosomura N; Kawaida H; Shoda K; Furuya S; Akaike H; Kawaguchi Y; Inoue S; Kono H; Ichikawa D
    World J Surg Oncol; 2022 Mar; 20(1):90. PubMed ID: 35317819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-Stage Ruptured Hepatocellular Carcinoma With Different Tumor Diameters: Small Tumors Have a Better Prognosis.
    Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Zhang B; Zhu P
    Front Oncol; 2022; 12():865696. PubMed ID: 35656507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis.
    Liu X; Li H; Wang F; Su K; He B; He J; Zhong J; Han Y; Li Z
    BMC Gastroenterol; 2023 Sep; 23(1):299. PubMed ID: 37670232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional survival in patients with spontaneous tumor rupture of hepatocellular carcinoma after partial hepatectomy: a propensity score matching analysis.
    Zhu Q; Qiao G; Xu C; Yu X; Zhao J; Yu Z; Hu M; Yang Y; Wang L; Lu M; Hu F; Cheng Z; Zhou J
    HPB (Oxford); 2019 Jun; 21(6):722-730. PubMed ID: 30389432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
    Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
    JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of ruptured liver segment IV hepatocellular carcinoma: is transarterial embolization (TAE) superior to chemoembolization (TACE)?-the jury is still out.
    Bakopoulos A; Koliakos N; Tsilimigras DI; Schizas D; Moris D; Angelopoulos A; Spanakos S; Spartalis E; Patapis P; Skandalakis P; Troupis T
    Ann Transl Med; 2018 Jul; 6(13):272. PubMed ID: 30094258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study.
    Wei F; Huang Q; Zhou Y; Luo L; Zeng Y
    World J Surg Oncol; 2021 Jun; 19(1):175. PubMed ID: 34127007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous rupture of hepatocellular carcinoma: a Western experience.
    Battula N; Madanur M; Priest O; Srinivasan P; O'Grady J; Heneghan MA; Bowles M; Muiesan P; Heaton N; Rela M
    Am J Surg; 2009 Feb; 197(2):164-7. PubMed ID: 18926518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy.
    Chen JL; Chen YS; Ker CG
    World J Gastrointest Surg; 2023 Feb; 15(2):258-272. PubMed ID: 36896302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the number of hepatic inflow occlusion times on the prognosis of ruptured hepatocellular carcinoma patients after hepatectomy.
    Xia F; Huang Z; Ndhlovu E; Zhang M; Chen X; Zhang B; Zhu P
    BMC Surg; 2022 Mar; 22(1):94. PubMed ID: 35282826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of ruptured hepatocellular carcinoma.
    Tanaka A; Takeda R; Mukaihara S; Hayakawa K; Shibata T; Itoh K; Nishida N; Nakao K; Fukuda Y; Chiba T; Yamaoka Y
    Int J Clin Oncol; 2001 Dec; 6(6):291-5. PubMed ID: 11828948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ruptured Hepatocellular Carcinoma: Current Status of Research.
    Xia F; Ndhlovu E; Zhang M; Chen X; Zhang B; Zhu P
    Front Oncol; 2022; 12():848903. PubMed ID: 35252016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.